Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Thrombopoietin receptor agonists: ten years later.

Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB.

Haematologica. 2019 Jun;104(6):1112-1123. doi: 10.3324/haematol.2018.212845. Epub 2019 May 9. Review.

2.

Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia.

Adelborg K, Kristensen NR, Nørgaard M, Bahmanyar S, Ghanima W, Kilpatrick K, Frederiksen H, Ekstrand C, Sørensen HT, Fynbo Christiansen C.

J Thromb Haemost. 2019 Jun;17(6):912-924. doi: 10.1111/jth.14446. Epub 2019 Apr 19.

PMID:
30933417
3.

Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.

Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM.

Platelets. 2019 Mar 18:1-8. doi: 10.1080/09537104.2019.1585527. [Epub ahead of print]

PMID:
30885035
4.

New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs.

Rutherford OW, Jonasson C, Ghanima W, Holst R, Halvorsen S.

Open Heart. 2018 Dec 9;5(2):e000931. doi: 10.1136/openhrt-2018-000931. eCollection 2018.

5.

Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group.

Birgegard G, Samuelsson J, Ahlstrand E, Ejerblad E, Enevold C, Ghanima W, Hasselbalch H, Nielsen CH, Knutsen H, Pedersen OB, Sørensen A, Andreasson B.

Eur J Haematol. 2019 Mar;102(3):235-240. doi: 10.1111/ejh.13198. Epub 2019 Jan 1.

PMID:
30472746
6.

Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies.

Fronas SG, Wik HS, Dahm AEA, Jørgensen CT, Gleditsch J, Raouf N, Klok FA, Ghanima W.

J Thromb Haemost. 2018 Dec;16(12):2471-2481. doi: 10.1111/jth.14314. Epub 2018 Nov 20.

PMID:
30303610
7.

The impact of post-pulmonary embolism syndrome and its possible determinants.

Tavoly M, Wik HS, Sirnes PA, Jelsness-Jørgensen LP, Ghanima JP, Klok FA, Sandset PM, Ghanima W.

Thromb Res. 2018 Nov;171:84-91. doi: 10.1016/j.thromres.2018.09.048. Epub 2018 Sep 15.

PMID:
30267974
8.

Adverse drug reactions upon use of new anticoagulants.

Ghanima W.

Tidsskr Nor Laegeforen. 2018 Aug 21;138(12). doi: 10.4045/tidsskr.18.0566. Print 2018 Aug 21. English, Norwegian. No abstract available.

9.

O-C.W. Rutherford og medarbeidere svarer.

Rutherford OW, König MSS, Risnes K, Raouf N, Atar D, Ghanima W.

Tidsskr Nor Laegeforen. 2018 Apr 17;138(7). doi: 10.4045/tidsskr.18.0238. Print 2018 Apr 17. Norwegian. No abstract available.

PMID:
29663755
Free Article
10.

Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants.

Andresen K, Atar D, Gjertsen E, Ghanima W, Roseth S, Johansen OE.

Scand Cardiovasc J. 2018 Jun;52(3):156-162. doi: 10.1080/14017431.2018.1453613. Epub 2018 Mar 23. Review.

PMID:
29569500
11.

Thromboembolism prophylaxis in patients with Philadelphia-negative myeloproliferative neoplasms-Clinical practice among Nordic specialists.

Bjerrum OW, Samuelsson J, Ghanima W, Kauppila M, Andersen CL; Nordic Myeloproliferative Neoplasm Study Group.

Eur J Haematol. 2018 May;100(5):475-478. doi: 10.1111/ejh.13043. Epub 2018 Mar 25.

PMID:
29427461
12.

[Antidote treatment during use of direct anticoagulants].

Rutherford OW, König MSS, Risnes K, Raouf N, Atar D, Ghanima W.

Tidsskr Nor Laegeforen. 2018 Feb 5;138(3). doi: 10.4045/tidsskr.17.0190. Print 2018 Feb 6. Review. Norwegian. No abstract available.

13.

Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms.

Lindgren M, Samuelsson J, Nilsson L, Knutsen H, Ghanima W, Westin J, Johansson PL, Andréasson B.

Eur J Haematol. 2018 May;100(5):419-425. doi: 10.1111/ejh.13034. Epub 2018 Mar 6.

PMID:
29369421
14.

[A man in his 50s with fever and anemia].

Nordtveit S, Lerum TV, Ghanima W, Berentsen S.

Tidsskr Nor Laegeforen. 2018 Jan 22;138(2). doi: 10.4045/tidsskr.17.0460. Print 2018 Jan 23. Norwegian. No abstract available.

15.

Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome.

Utne KK, Dahm A, Wik HS, Jelsness-Jørgensen LP, Sandset PM, Ghanima W.

Thromb Res. 2018 Mar;163:6-11. doi: 10.1016/j.thromres.2018.01.013. Epub 2018 Jan 8.

PMID:
29324334
16.

Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.

Ghanima W, Boiocchi L, Lee CS, Feng X, Geyer JT, Gudbrandsdottir S, Orazi A, Junker P, Bussel JB.

Platelets. 2019;30(2):222-228. doi: 10.1080/09537104.2017.1411586. Epub 2018 Jan 2.

PMID:
29293383
17.

Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia.

Garabet L, Ghanima W, Monceyron Jonassen C, Skov V, Holst R, Mowinckel MC, C Hasselbalch H, A Kruse T, Thomassen M, Liebman H, Bussel JB, Sandset PM.

Platelets. 2019;30(2):206-212. doi: 10.1080/09537104.2017.1394451. Epub 2017 Dec 7.

PMID:
29215956
18.

JAK2 V617F mutation can be reliably detected in serum using droplet digital PCR.

Nystrand CF, Ghanima W, Waage A, Jonassen CM.

Int J Lab Hematol. 2018 Apr;40(2):181-186. doi: 10.1111/ijlh.12762. Epub 2017 Nov 17.

PMID:
29150911
19.

Diagnostic scales for the post-thrombotic syndrome.

Wik HS, Enden TR, Ghanima W, Engeseth M, Kahn SR, Sandset PM.

Thromb Res. 2018 Apr;164:110-115. doi: 10.1016/j.thromres.2017.10.022. Epub 2017 Oct 28. Review.

PMID:
29126608
20.

Evaluating patient experiences in decentralised acute care using the Picker Patient Experience Questionnaire; methodological and clinical findings.

Leonardsen AL, Grøndahl VA, Ghanima W, Storeheier E, Schönbeck A, Løken TA, Bakken NCM, Letting GS, Holst R, Jelsness-Jørgensen LP.

BMC Health Serv Res. 2017 Sep 29;17(1):685. doi: 10.1186/s12913-017-2614-4.

21.

Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism.

Ghanima W, Wik HS, Tavoly M, Enden T, Jelsness-Jørgensen LP.

Thromb Res. 2018 Apr;164:170-176. doi: 10.1016/j.thromres.2017.07.025. Epub 2017 Jul 23.

PMID:
28760416
22.

Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012.

Rørholt M, Ghanima W, Farkas DK, Nørgaard M.

Haematologica. 2017 Aug;102(8):1333-1341. doi: 10.3324/haematol.2016.157008. Epub 2017 Jun 1.

23.

Scoring Systems for Postthrombotic Syndrome.

Wik HS, Ghanima W, Sandset PM, Kahn SR.

Semin Thromb Hemost. 2017 Jul;43(5):500-504. doi: 10.1055/s-0037-1599142. Epub 2017 May 3. Review.

PMID:
28470653
24.

Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years.

Barzenje DA, Kolstad A, Ghanima W, Holte H.

Hematol Oncol. 2018 Feb;36(1):217-223. doi: 10.1002/hon.2415. Epub 2017 Apr 9.

PMID:
28393375
25.

[New direct-acting anticoagulants for cancer patients?].

Dahm AE, Ghanima W.

Tidsskr Nor Laegeforen. 2017 Feb 7;137(3):171-172. doi: 10.4045/tidsskr.17.0008. eCollection 2017 Feb. Norwegian. No abstract available.

26.

Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP).

Gudbrandsdottir S, Ghanima W, Nielsen CH, Feng X, Hasselbalch HC, Bussel J.

Platelets. 2017 Jul;28(5):478-483. doi: 10.1080/09537104.2016.1235691. Epub 2016 Nov 7.

PMID:
27819522
27.

Health-related quality of life after pulmonary embolism: a cross-sectional study.

Tavoly M, Utne KK, Jelsness-Jørgensen LP, Wik HS, Klok FA, Sandset PM, Ghanima W.

BMJ Open. 2016 Nov 3;6(11):e013086. doi: 10.1136/bmjopen-2016-013086.

28.

New anticoagulants in combination with antiplatelet agents.

Johansen H, Rutherford OW, Aamodt AH, Russell D, Atar D, Ghanima W.

Tidsskr Nor Laegeforen. 2016 Oct 11;136(18):1543-1546. eCollection 2016 Oct. Review. English, Norwegian.

29.

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.

Halvorsen S, Ghanima W, Fride Tvete I, Hoxmark C, Falck P, Solli O, Jonasson C.

Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):28-36. doi: 10.1093/ehjcvp/pvw031. Epub 2016 Sep 27.

30.

Response of first line treatment with corticosteroids in a population-based cohort of adults with primary immune thrombocytopenia.

Frederiksen H, Ghanima W.

Eur J Intern Med. 2017 Jan;37:e23-e25. doi: 10.1016/j.ejim.2016.09.001. Epub 2016 Sep 12. No abstract available.

PMID:
27633568
31.

A qualitative study of patient experiences of decentralized acute healthcare services.

Linqvist Leonardsen AC, Del Busso L, Abrahamsen Grøndahl V, Ghanima W, Barach P, Jelsness-Jørgensen LP.

Scand J Prim Health Care. 2016 Sep;34(3):317-24. doi: 10.1080/02813432.2016.1222200. Epub 2016 Aug 25.

32.

Health-related quality of life after deep vein thrombosis.

Utne KK, Tavoly M, Wik HS, Jelsness-Jørgensen LP, Holst R, Sandset PM, Ghanima W.

Springerplus. 2016 Aug 8;5(1):1278. doi: 10.1186/s40064-016-2949-z. eCollection 2016.

33.

General practitioners' perspectives on referring patients to decentralized acute health care.

Leonardsen AL, Del Busso L, Grøndahl VA, Ghanima W, Jelsness-Jørgensen LP.

Fam Pract. 2016 Dec;33(6):709-714. Epub 2016 Aug 20.

PMID:
27543796
34.

Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.

Roaldsnes C, Holst R, Frederiksen H, Ghanima W.

Eur J Haematol. 2017 Jan;98(1):85-93. doi: 10.1111/ejh.12788. Epub 2016 Sep 4.

PMID:
27500783
35.

Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma.

Barzenje DA, Holte H, Fosså A, Ghanima W, Liestøl K, Delabie J, Kolstad A.

Leuk Lymphoma. 2017 Mar;58(3):623-632. doi: 10.1080/10428194.2016.1204653. Epub 2016 Jul 7.

PMID:
27389974
36.

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.

Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM; CaVenT Study Group.

Lancet Haematol. 2016 Feb;3(2):e64-71. doi: 10.1016/S2352-3026(15)00248-3. Epub 2016 Jan 6.

PMID:
26853645
37.

Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis.

Chugh S, Darvish-Kazem S, Lim W, Crowther MA, Ghanima W, Wang G, Heddle NM, Kelton JG, Arnold DM.

Lancet Haematol. 2015 Feb;2(2):e75-81. doi: 10.1016/S2352-3026(15)00003-4. Epub 2015 Feb 5. Review.

PMID:
26687612
38.

Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study.

Nørgaard M, Cetin K, Maegbaek ML, Kristensen NR, Ghanima W, Bahmanyar S, Stryker S, Christiansen CF.

Br J Haematol. 2016 Aug;174(4):639-42. doi: 10.1111/bjh.13787. Epub 2015 Oct 12. No abstract available.

PMID:
26456477
39.

Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome.

Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS.

Thromb Haemost. 2016 Jan;115(2):361-7. doi: 10.1160/TH15-04-0318. Epub 2015 Sep 17.

PMID:
26422814
40.

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.

Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA; RITP study group.

Lancet. 2015 Apr 25;385(9978):1653-61. doi: 10.1016/S0140-6736(14)61495-1. Epub 2015 Feb 5.

PMID:
25662413
41.

Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort.

Tavoly M, Jelsness-Jørgensen LP, Wik HS, Roaldsnes C, Sandset PM, Ghanima W.

Qual Life Res. 2015 Feb;24(2):417-25. doi: 10.1007/s11136-014-0779-4. Epub 2014 Aug 14.

PMID:
25120017
42.

Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.

Bussel JB, Lee CS, Seery C, Imahiyerobo AA, Thompson MV, Catellier D, Turenne IG, Patel VL, Basciano PA, Elstrom RL, Ghanima W.

Haematologica. 2014 Jul;99(7):1264-71. doi: 10.3324/haematol.2013.103291. Epub 2014 Apr 18.

43.

Pain and bleeding associated with trephine biopsy.

Valebjørg T, Spahic B, Bremtun F, Kahrs J, Hammerstrøm J, Brudevold R, Kolflaath J, Ghanima W.

Eur J Haematol. 2014 Oct;93(4):267-72. doi: 10.1111/ejh.12339. Epub 2014 Apr 30.

PMID:
24725088
44.

Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up.

Ghanima W, Geyer JT, Lee CS, Boiocchi L, Imahiyerobo AA, Orazi A, Bussel JB.

Haematologica. 2014 May;99(5):937-44. doi: 10.3324/haematol.2013.098921. Epub 2014 Jan 24.

45.

[Primary myelofibrosis--pathogenesis, diagnosis and treatment].

Ghanima W, Knutsen H, Delabie J, Bruserud Ø.

Tidsskr Nor Laegeforen. 2013 Oct 1;133(18):1946-50. doi: 10.4045/tidsskr.12.1106. Review. Norwegian.

46.

New oral anticoagulants--a review.

Ghanima W, Atar D, Sandset PM.

Tidsskr Nor Laegeforen. 2013 Oct 1;133(18):1940-5. doi: 10.4045/tidsskr.12.1111. Review. English, Norwegian.

47.

Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.

Ghanima W, Lee SY, Barsam S, Miller A, Sandset PM, Bussel JB.

Br J Haematol. 2012 Sep;158(6):811-4. doi: 10.1111/j.1365-2141.2012.09227.x. Epub 2012 Jul 23. No abstract available.

PMID:
22816787
48.

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment.

Ghanima W, Godeau B, Cines DB, Bussel JB.

Blood. 2012 Aug 2;120(5):960-9. doi: 10.1182/blood-2011-12-309153. Epub 2012 Jun 26. Review.

49.

Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.

Feng X, Scheinberg P, Samsel L, Rios O, Chen J, McCoy JP Jr, Ghanima W, Bussel JB, Young NS.

J Thromb Haemost. 2012 Aug;10(8):1616-23. doi: 10.1111/j.1538-7836.2012.04757.x.

50.

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM; CaVenT Study Group.

Lancet. 2012 Jan 7;379(9810):31-8. doi: 10.1016/S0140-6736(11)61753-4. Epub 2011 Dec 13.

PMID:
22172244

Supplemental Content

Loading ...
Support Center